Ovid Therapeutics Inc (NASDAQ:OVID)

3.82
BATS BZX Real-Time Price
As of 2:40pm ET
 -0.03 / -0.78%
Today’s Change
2.25
Today|||52-Week Range
9.40
+65.37%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +57.07% increase from the last price of 3.82.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.45
Sales
$2.4M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 527.29%
 
 
 
 
 
 
Growthannually 166.80%
 
 
 
 
 
 

Sales

Growthquarterly -58.43%
 
 
 
 
 
 
Growthannually -42.37%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.